It's probably very similar for most industrialized countries to some extent. In Netherland (which probably has the most expensive health care in Europe), insurance companies negotiate about the prices, which means those companies decide which medicine is and isn't covered, and while they still have a reasonable amount of negotiating power, it's not as much as that of a more centralized approach. Still better than the US approach, but certainly the weakest of the EU.